Susquehanna International Group
KNSA icon

Susquehanna International Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Susquehanna International Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294K Sell
6,100
-43,200
-88% -$1.91M ﹤0.01% 10903
2025
Q4 		$2.03M Buy
+49,300
New +$1.98M ﹤0.01% 5634
2025
Q3 		– Sell
-115,400
Closed -$3.19M – 13200
2025
Q2 		$3.19M Buy
+115,400
New +$2.94M ﹤0.01% 4841
2025
Q1 		– Sell
-60,800
Closed -$1.2M – 13013
2024
Q4 		$1.2M Buy
60,800
+22,800
+60% +$520K ﹤0.01% 6508
2024
Q3 		$950K Sell
38,000
-27,900
-42% -$680K ﹤0.01% 6900
2024
Q2 		$1.23M Sell
65,900
-56,200
-46% -$1.05M ﹤0.01% 6092
2024
Q1 		$2.41M Buy
122,100
+74,400
+156% +$1.45M ﹤0.01% 4937
2023
Q4 		$837K Buy
47,700
+13,700
+40% +$225K ﹤0.01% 7424
2023
Q3 		$591K Buy
34,000
+22,700
+201% +$382K ﹤0.01% 7843
2023
Q2 		$159K Buy
+11,300
New +$151K ﹤0.01% 10517
2022
Q4 		– Sell
-28,600
Closed -$367K – 13082
2022
Q3 		$367K Sell
28,600
-6,500
-19% -$74.1K ﹤0.01% 9292
2022
Q2 		$340K Buy
+35,100
New +$328K ﹤0.01% 9228
2022
Q1 		– Sell
-62,000
Closed -$730K – 13527
2021
Q4 		$730K Sell
62,000
-37,700
-38% -$463K ﹤0.01% 8132
2021
Q3 		$1.14M Buy
99,700
+11,900
+14% +$155K ﹤0.01% 7234
2021
Q2 		$1.22M Sell
87,800
-23,900
-21% -$363K ﹤0.01% 7184
2021
Q1 		$2.07M Buy
111,700
+73,200
+190% +$1.5M ﹤0.01% 5837
2020
Q4 		$680K Buy
38,500
+20,400
+113% +$358K ﹤0.01% 7617
2020
Q3 		$277K Sell
18,100
-15,000
-45% -$282K ﹤0.01% 8872
2020
Q2 		$843K Buy
+33,100
New +$691K ﹤0.01% 6279

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Susquehanna International Group's KNSA Position: Q1 2026 in Review

Susquehanna International Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 795% in Q1 2026, buying an estimated $15.1M and bringing the position to 383,811 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Susquehanna International Group first reported a position in KNSA in Q3 2020 and has held it in 21 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Susquehanna International Group held 383,811 shares of Kiniksa Pharmaceuticals worth $18.5M as of Q1 2026.
  • Susquehanna International Group bought 340,914 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $15.1M.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2333 holding.
  • Susquehanna International Group first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.